Fig. 1From: In silico analysis of HLA-1 and HLA-2 recognition of a designed recombinant human papillomavirus vaccine based on L1 protein HPV subtype 45Schematic representation of the study workflow. Two parts were performed during the study. A Part one was the analysis of the L1 recombinant protein binding to HLA-1 and 2 Epitopes. B Part two was the distribution analysis of HPV-linked HLA alleleBack to article page